In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kite Pharma Inc.

Division of Gilead Sciences Inc.
www.kitepharma.com

Latest From Kite Pharma Inc.

Orphan Products: US FDA Working On ‘Sameness’ Policy For Cell And Gene Therapies

Industry seeks clarity as to when a subsequent product will be judged the ‘same’ as a previously approved product that holds seven years of blocking exclusivity. CBER Director Marks says agency is working to put its views in writing soon but notes the US and EU may be headed in different directions on the issue.

Gene Therapy Rare Diseases

EMA Discusses Pivotal Role Of RWE For Six Drugs

The European Medicines Agency explains how it used real-word evidence during recent deliberations for six products. 
Europe Drug Approval Standards

Biktarvy, PrEP Continue Driving Gilead’s HIV Dominance

HIV remains the main growth franchise for Gilead, despite an anticipated first quarter revenue downturn due to inventory and payer mix. Biktarvy’s launch and growth in PrEP business provide multiple drivers for the franchise.

Business Strategies Commercial

Gilead To Let Kite Fly Free; O’Day Says It Will Become Separate Business Unit

On his first earnings call, the new CEO said he wanted to make a quick decision on Kite, which will have its own CEO and autonomy. The unit's Yescarta posted 19% sequential revenue growth.

Sales & Earnings ImmunoOncology
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Gilead Sciences Inc.
  • Senior Management
  • Contact Info
  • Kite Pharma Inc.
    Phone: (650) 574-3000
    333 Lakeside Dr.
    Foster City, CA 90404
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register